Higher Psychotropic Medication Use in Elderly Residents with Dementia
Research indicates that residents with dementia in aged care are prescribed antipsychotic medications at twice the rate of those without dementia, highlighting ongoing challenges in safe medication management for older adults.
Recent research from Macquarie University reveals that residents living with dementia in aged care facilities are prescribed antipsychotic medications at twice the rate of those without dementia. This first-ever comprehensive national study examined medication usage across 428 aged care facilities in Australia from 2018 to 2022, highlighting both progress and ongoing challenges in managing psychotropic drug use among older adults.
The study found a significant decline in the overall use of antipsychotics, sedatives, and antiseizure medications over the four-year period, which analysts attribute to reforms implemented following the 2018 Royal Commission into aged care. These reforms included stricter regulatory oversight, enhanced dementia support services, systematic medication reviews, and the adoption of quality indicators aimed at reducing unnecessary prescribing.
Despite these positive trends, the data indicates that the use of antipsychotics among residents with dementia remains alarmingly high—around 23% in 2022—twice that of residents without dementia. Moreover, there has been an increase in antidepressant prescriptions within this group, rising from 42% to 48%. While some healthcare providers perceive antidepressants as safer alternatives, experts warn that these medications also carry risks and limited evidence of benefit for behavioral symptoms linked to dementia.
The findings underscore that although regulatory and clinical efforts are steering care towards safer practices, further work is necessary. Persistent overprescribing of high-risk medications highlights a need for continuous workforce training, improved care strategies, and vigilant medication management to optimize treatment for this vulnerable population.
Associates Professor Magda Raban emphasizes that reducing unnecessary psychotropic use requires a collaborative approach involving aged care providers, clinicians, and families. Leveraging technology, ongoing training, and robust monitoring are essential steps toward ensuring the well-being and safety of older adults living with dementia.
Source: https://medicalxpress.com/news/2025-09-psychotics-high-aged-residents-dementia.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Decline in Preventive Heart Screenings Among Disabled Adults During the Pandemic
A new study reveals that preventive heart screenings for adults with disabilities declined sharply during the COVID-19 pandemic, worsening existing healthcare disparities. Learn about the implications and needed improvements in care access.
Innovative Pulsed Low Dose Rate Chemoradiation Significantly Lowers Side Effects in Cancer Treatment
A cutting-edge pulsed low dose rate chemoradiation therapy has shown promise in reducing side effects for esophageal and lung cancer patients, maintaining treatment effectiveness while improving patient comfort.
Majority of U.S. Neurologists Prescribing Multiple Sclerosis Medications Have Received Industry Payments, Study Reveals
A new study reveals that nearly 80% of U.S. neurologists prescribing multiple sclerosis drugs have received payments from pharmaceutical companies, influencing prescribing practices and healthcare costs.
Study Finds White Veterans as High Users of Secure Messaging in Veteran Health System
A recent study reveals that White veterans are more active in using secure messaging portals in the Veterans Health Administration, with implications for personalized healthcare outreach and resource allocation.